26 results
8-K
EX-3.2
SGTX
Sigilon Therapeutics Inc
11 Aug 23
Completion of Acquisition or Disposition of Assets
4:16pm
be a conflict of interest between the Corporation and the claimant in the conduct of the defense of such proceeding or (iii) the Corporation shall … of the same matter unless the representation of the claimant and such other person(s) gives rise to an actual or potential conflict of interest
SC 14D9
EX-99
SGTX
Sigilon Therapeutics Inc
13 Jul 23
Tender offer solicitation
8:18am
not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing
SC 14D9
SGTX
Sigilon Therapeutics Inc
13 Jul 23
Tender offer solicitation
8:18am
transactions. Lazard also highlighted a potential conflict of interest relating to its representation of the Company with respect to Party A. After … Board determined that these directors would have a potential conflict of interest if the Company was pursing transactions with such counterparties
S-3
EX-1.2
su0 lvnrmqswzz1evx
14 Apr 22
Shelf registration
4:34pm
10-Q
s91gw0d2axau257p
10 May 21
Quarterly report
4:31pm
DEF 14A
a0flhquk5ua2gz35du
27 Apr 21
Definitive proxy
4:49pm
10-K
r2fb7ew
18 Mar 21
Annual report
4:31pm
424B4
ubtyw9jcs2eb2oqz9
7 Dec 20
Prospectus supplement with pricing info
9:10am
S-1/A
wwea 78sadiqhpe1umm
30 Nov 20
IPO registration (amended)
6:41am
S-1
EX-10.15
nh14qz8kaahp5
13 Nov 20
IPO registration
3:27pm
S-1
p5y4b
13 Nov 20
IPO registration
3:27pm